LifeStance Health Group, Inc. (LFST) company profile
Close on Nov 16, 2026Market cap $5.53BP/E 111.4Yield –
About LifeStance Health
Services-Health Services, SIC 8000
LifeStance Health Group, Inc. operates an outpatient mental healthcare platform providing in-person and virtual behavioral health services. The company offers a multidisciplinary range of care, including psychiatric evaluations, psychological and neuropsychological testing, and individual, family, and group therapy. Clinicians treat diverse mental health conditions such as anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Services are delivered through employed clinicians and affiliated practices, serving patients primarily through in-network commercial insurance plans, government healthcare programs, and self-pay arrangements.
The organization operates across 33 states and employs 8,040 licensed mental health clinicians through its subsidiaries and supported practices. LifeStance delivers services via physical centers as well as its digital platform, partnering with primary care physicians, specialists, and health systems to coordinate care. The company maintains its corporate headquarters in Scottsdale, Arizona.
Summary of the business section of LifeStance Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- LifeStance Health Group, Inc.
- Headquarters
- Scottsdale, AZ
- Address
- 4800 N. Scottsdale Road, Suite 2500 85251
- Phone
- (602) 767-2100
- Website
- lifestance.com
- Employees
- 10,961, Dec 31, 2025
- Industry
- Services-Health Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Seattle, Washington
Stock & identifiers
- Ticker
- LFST
- Exchange
- Nasdaq
- IPO date
- Jun 11, 2021
- Shares outstanding
- 382M, Jul 29, 2026
- Public float
- $817.21M, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1845257
- CUSIP
- 53228F101
- ISIN
- US53228F1012
- FIGI
- BBG01138DGZ7
- Share class FIGI
- BBG01138DHT2
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| David Bourdon | Chief Executive Officer, Director | 1,248,247 |
| Ryan Pardo | See Remarks | 840,381 |
| Lisa K. Miller | Chief Operating Officer | 251,904 |
| Vukasin Paunovich | Chief Technology Officer | 205,379 |
| Ann Varanakis | Chief People Officer | 413,881 |
| Ryan McGroarty | See Remarks | 772,235 |
| Stephanie Carin Eken | Chief Medical Officer | 115,107 |
| Ujjwal Ramtekkar | Chief Medical Officer | 103,916 |
| Pablo Pantaleoni | Chief Digital Officer | 1,437,881 |
| Kenneth A. Burdick | Director | 3,642,777 |
| Teresa DeLuca | Director | 133,456 |
| Safwan Shabab | Director | – |
| Lori Goltermann | Director | 35,492 |
| Sarah Personette | Director | 92,512 |
| Thurman Justice | Director | 35,492 |
| Robert Bessler | Director | 1,308,051 |
| Eric P. Palmer | Director | 89,174 |
| Darren M. Black | Director | 23,310,115 |
| Eric Shuey | Director | 961,544 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 David Bourdon | $6.65M | $4.76M | $3.26M | $32 | $85 |
| FY2025 Kenneth Burdick | $7.12M | -$482.44K | $3.26M | $32 | $85 |
| FY2024 | $10.20M | $4.14M | $4.17M | $34 | $70 |
| FY2023 | $14.83M | $39.44M | $2.54M | $36 | $68 |
| FY2022 Kenneth Burdick | $40.95M | $27.35M | $9.48M | $23 | $65 |
| FY2022 Michael KLester | $9.81M | -$25.95M | $9.48M | $23 | $65 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| David Bourdon Chief Executive Officer | $657.69K | – | $5.26M | $716.07K | $14.00K | $6.65M | +93% |
| Ryan McGroarty Chief Financial Officer and Treasurer | $412.50K | $570.00K | $5.00M | $518.93K | $14.00K | $6.52M | – |
| Kenneth Burdick Executive Chairperson; Former Chief Executive Officer | $284.62K | – | $6.47M | $351.54K | $14.00K | $7.12M | -30% |
| Ryan Pardo Chief Legal Officer and Secretary | $350.00K | – | $2.02M | $194.25K | $14.00K | $2.58M | -1% |
| Ann Varanakis Chief People Officer | $350.00K | – | $1.26M | $194.25K | $14.00K | $1.82M | +9% |
| Vaughn Paunovich Chief Technology Officer | $251.83K | – | $1.33M | $186.82K | $8.63K | $1.78M | – |
| Pablo Pantaleoni Former Chief Digital Officer | $232.12K | – | $2.91M | – | $455.25K | $3.59M | +30% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Jun 11, 2021
- Offer price
- $18.00
- Securities offered
- 40,000,000
- Gross proceeds
- $720.00M
- Exchange
- Nasdaq
- First trading day
- Jun 10, 2021
- First-day close
- $21.90+21.7%
- Lock-up ends (est.)
- Dec 7, 2021
“See “Prospectus Summary—Implications of Being an Emerging Growth Company.” Per share Total Initial public offering price $ 18.00 $ 720,000,000 Underwriting discounts and commissions (1) $ 0.99 $ 39,600,000 Proceeds to us before expenses $ 17.01 $ 557,928,000 Proceeds to the selling stockholders $ 17.01 $ 122,472,000 (1) We have agreed to reimburse the underwriters for certain expenses in”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed approximately 10,961 employees through our subsidiaries and supported practices, of which 4,549 were directly employed through our subsidiaries and 6,412 were directly employed by our supported practices.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 11, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Jun 10, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?